OT Roundup debuts with new ADHD ocular findings, a surgeon's own trifocal IOL journey, MOGENRY's FDA filing, and myopia policy news.
OT Roundup
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
Remigromig noninferior to ranibizumab in phase 2b/3 BRUNELLO DME trial
2
ESCRS 2026: Q&A: What early real-world data reveal about the TECNIS Odyssey
3
Transforming Glaucoma Management: Next-Generation Laser Technology for Everyday Clinical Practice
4
"Time is vision": EURETINA President Nicole Eter, MD, previews the 2026 congress
5